Evidence map›Paper›PMID 42198347›Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

Evaluation of the Potential Anti-Inflammatory Effect of a New Coumarin-Quinoline Hybrid in LPS-Induced Neuroinflammation.

Omnia Hamdy Mohamed Shehata, Eman Abdelaziz, Hadeer Ali, Elshaymaa I Elmongy, Reem Binsuwaidan, Wafaa M Ibrahim, Sabreen El-Gamasy, Ibrahim El Tantawy El Sayed

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Omnia Hamdy Mohamed ShehataDepartment of Chemistry, Faculty of Science, Menoufia University, Shebin El-Kom 32512, Egypt.ORCID 0009-0007-0482-7127
Eman AbdelazizDepartment of Chemistry, Faculty of Science, Menoufia University, Shebin El-Kom 32512, Egypt.
Hadeer AliDepartment of Chemistry, Faculty of Science, Menoufia University, Shebin El-Kom 32512, Egypt.
Elshaymaa I ElmongyPharmaceutical Chemistry Department, Faculty of Pharmacy, Capital University (Formerly Helwan University), Ein Helwan, Cairo 11795, Egypt.ORCID 0000-0003-1160-5040
Reem BinsuwaidanDepartment of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah Bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.ORCID 0000-0003-1406-282X
Wafaa M IbrahimDepartment of Medical Biochemistry, Faculty of Medicine, Tanta University, Tanta 31511, Egypt.
Sabreen El-GamasyDepartment of Chemistry, Faculty of Science, Menoufia University, Shebin El-Kom 32512, Egypt.
Ibrahim El Tantawy El SayedDepartment of Chemistry, Faculty of Science, Menoufia University, Shebin El-Kom 32512, Egypt.ORCID 0000-0003-1227-7931

Funding

Princess Nourah bint Abdulrahman University Researchers Supporting PNURSP2026R304
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

and NF-κBcoumarin–quinoline hybridLPSneuroinflammationNLRP3

Identifiers

PMID42198347
PMCPMC13210173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.